Merck KGaA Appoints New Executive Board Chair, CEO
September 28 2020 - 9:20AM
Dow Jones News
By Giulia Petroni
Merck KGaA said Monday that it has appointed Belen Garijo as
chair of the executive board and chief executive officer effective
from May 1, 2021.
Ms. Garijo is currently vice chair of the board and deputy CEO
as well as CEO of Healthcare. She will succeed Stefan Oschmann, who
will leave the company as planned "to turn to other tasks," the
German pharmaceuticals and chemicals company said.
Merck also said Peter Guenter will join the executive board of
the company and assume responsibility of the Healthcare business
sector effective from Jan. 1, 2021 at the latest.
Matthias Heinzel will also join the board and be responsible for
Life Science effective from April 1, 2021 at the latest.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
September 28, 2020 09:05 ET (13:05 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck KGaA (PK) (USOTC:MKKGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
